Navigation Links
febit Appoints Michelle Lyles, Ph.D., Vice President, Marketing and Sales

MEDFORD, Mass. and HEIDELBERG, Germany, March 10 /PRNewswire/ -- febit holding gmbh today announced the appointment of Michelle Lyles, Ph.D., to the newly created position of vice president, marketing and sales. She will be based in febit inc.'s U.S. headquarters, which is located near Boston in Medford, Mass.

Lyles will manage the US marketing and sales initiatives for febit's genomics technology products and services. These initiatives will include the company's launch of the Geniom(R) RT Analyzer, a fully automated instrument for the hybridization, washing, staining and scanning of microarrays, in the second quarter of this year.

"This is an exciting phase for febit, with the upcoming launch of the Geniom RT Analyzer," said Cord. F. Staehler, president and CEO of febit. "The addition of Michelle to the growing febit team is an important step -- in expanding our presence in the USA, the world's most important market for innovative genomics research products and services."

Lyles has extensive sales and marketing experience in the life sciences industry. Prior to joining febit, she was director of sales with Sigma-Aldrich Corp.'s research biotechnology business unit, where she successfully grew key businesses, built the sales team and created sales processes. Before this, Lyles was vice president of sales and marketing with Genospectra Inc. Earlier in her career, she was a technology manager for high-throughput screening (HTS) systems with PerkinElmer Inc., and product manager for the BioChip Array and sales development manager for HTS assay platforms with Packard Biosciences Co.

"I am thrilled to help bring febit's technology offering to full fruition by putting it in the hands of the life sciences research community," said Lyles. "febit's pioneering technology and team of highly experienced scientists position the company as a leader in genomics."

Lyles earned her Ph.D. in biochemistry at Baylor College of Medicine and completed post-doctoral training at Emory University. She holds a B.S. in biology and a B.S. in chemistry from the University of New Orleans.

About febit

febit enables scientists to read, write and understand the code of life: DNA. With its unique Geniom technology products and services, febit is the only company that puts the control for simplified genomics research directly into users' hands. Geniom exploits cutting-edge microarray technology for the analysis and synthesis of genes and genomes, providing superior time- and cost-efficiency combined with an unsurpassed spectrum of applications. Many world-renowned institutions and companies use Geniom today to drive their basic and applied research. For more information, visit


febit holding gmbh Russo Partners, LLC

Eva Sterzel David Schull or Wendy Lau

Public Relations Manager +1-212-845-4271

+49 (6221) 6510-300

SOURCE febit
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Elusys Therapeutics Appoints Robert Gundel as Vice President of Research
2. Spectral appoints Anthony Bihl to Board of Directors
3. Tianyin Pharmaceutical Appoints Three New Independent Board Members
4. Hiemstra Appoints Robert C. Glines as Director of Business Development
5. Tengion Appoints Jeff Randall to Board of Directors
6. Ambrx Appoints Douglas Axelrod Senior Vice President for Clinical Research and Development
7. BioStorage Technologies Appoints Dr. Wolfgang Hoffer as Managing Director of European Operations
8. Stem Cell Company t2cure Appoints Dr Rueck Head of Clinical Operations
9. Human Genome Sciences Appoints Maxine Gowen, Ph.D., to Its Board Of Directors
10. ImmunoVaccine Technologies appoints the Honourable Michael Kirby as Chair
11. China Technology Appoints Deloitte Touche Tohmatsu CPA as Independent Auditor
Post Your Comments:
(Date:6/23/2016)... 2016   EpiBiome , a precision microbiome engineering ... debt financing from Silicon Valley Bank (SVB). The financing ... advance its drug development efforts, as well as purchase ... "SVB has been an incredible strategic partner to us ... bank would provide," said Dr. Aeron Tynes Hammack ...
(Date:6/23/2016)... LOUISVILLE, Ky. , June 23, 2016 /PRNewswire/ ... from two Phase 1 clinical trials of its ... double-blind, placebo-controlled, single and multiple ascending dose studies ... and pharmacodynamics (PD) of subcutaneous injection in healthy ... APL-2 subcutaneously (SC) either as a single dose ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the only free ... and will showcase its product’s latest features from June 26 to June 30, ... poster on Disrupting Clinical Trials in The Cloud during the conference. DIA ...
(Date:6/23/2016)... 23, 2016 adds ... to its pharmaceuticals section with historic and forecast ... much more. Complete report on the ... profiling 15 companies and supported with 261 tables ... . The Global Cell Culture ...
Breaking Biology Technology:
(Date:4/26/2016)... , April 27, 2016 ... the  "Global Multi-modal Biometrics Market 2016-2020"  report to ... ) , The analysts forecast the ... CAGR of 15.49% during the period 2016-2020.  ... number of sectors such as the healthcare, BFSI, ...
(Date:4/13/2016)... , April 13, 2016  IMPOWER physicians supporting ... are setting a new clinical standard in telehealth thanks ... By leveraging the higi platform, IMPOWER patients can routinely ... pulse and body mass index, and, when they opt ... and convenient visit to a local retail location at ...
(Date:3/22/2016)... 22, 2016 According ... Market for Consumer Industry by Type (Image, Motion, ... (Communication & IT, Entertainment, Home Appliances, & ... to 2022", published by MarketsandMarkets, the market ... reach USD 26.76 Billion by 2022, at ...
Breaking Biology News(10 mins):